Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps NHS England will take to ensure Integrated Care Boards comply with Regulation 6(4) of the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013, particularly where chemist premises are removed following a consolidation application, but no Supplementary Statement is publicly published to confirm that the relevant Health and Wellbeing Board is satisfied that no gap in service provision was created.

If two pharmacies are consolidated onto one site, the relevant Local Authority Health and Wellbeing Board (HWB) must publish a supplementary statement to their Pharmaceutical Needs Assessment if, in their view, the consolidation has not created a gap in service provision. This requirement is set out in Regulation 6(4) of the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013. Whilst it is not the responsibility of NHS England to ensure HWBs comply with this requirement, integrated care boards (ICBs) must seek assurance that a closure of a pharmacy would not create a gap when considering consolidation applications. This includes seeking the view of the HWB. Any representations received from the HWB are considered when reviewing an application from a contractor to open a pharmacy in the area. NHS England oversees the performance of ICBs through the NHS Oversight Framework 2025/26 and the Strategic Commissioning Framework.